• 1. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. Achieving high-efficiency purely organic room-temperature phosphorescence materials by boronic ester substitution of phenoxathiine?
  Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
• 4. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

Comprehensive Overview of 7-methyl-6-oxa-9-azaspiro[4.5]decane (CAS No. 1018608-06-4): Properties, Applications, and Research Insights

The compound 7-methyl-6-oxa-9-azaspiro[4.5]decane (CAS No. 1018608-06-4) is a structurally unique spirocyclic molecule that has garnered significant attention in pharmaceutical and chemical research. Its spirocyclic framework, featuring both oxygen and nitrogen heteroatoms, makes it a versatile scaffold for drug discovery and material science. This article delves into its molecular properties, synthetic routes, and potential applications, while addressing trending queries such as "spirocyclic compounds in drug design" and "heterocyclic chemistry advancements."

From a structural perspective, 7-methyl-6-oxa-9-azaspiro[4.5]decane combines a tetrahydrofuran (oxygen-containing) ring and a piperidine (nitrogen-containing) ring, linked via a spiro carbon. This arrangement imparts conformational rigidity, a trait highly sought after in medicinal chemistry for targeting specific biological pathways. Researchers often explore its derivatives for CNS-active compounds, given the prevalence of similar scaffolds in neuropharmacology. Searches like "spirocyclic CNS drugs" and "aza-spiro compounds solubility" reflect growing interest in its pharmacokinetic optimization.

The synthesis of 7-methyl-6-oxa-9-azaspiro[4.5]decane typically involves multistep organic reactions, including cyclization and functional group transformations. Recent publications highlight catalytic asymmetric methods to access enantiopure forms, addressing the demand for "chiral spirocyclic synthesis"—a hot topic in synthetic chemistry forums. Its CAS registry number (1018608-06-4) serves as a critical identifier for researchers sourcing the compound for high-throughput screening or structure-activity relationship (SAR) studies.

In pharmaceutical applications, this spirocyclic system is often functionalized to modulate bioavailability and target selectivity. For instance, its derivatives are investigated for GPCR modulation—a trending search term linked to neurodegenerative and metabolic disorders. The compound’s logP and hydrogen-bonding capacity (frequently queried as "spirocycle ADME properties") make it a candidate for blood-brain barrier penetration studies.

Beyond therapeutics, 7-methyl-6-oxa-9-azaspiro[4.5]decane finds niche roles in material science, particularly in designing supramolecular architectures. Its rigid backbone aids in creating porous organic polymers (POPs), a field gaining traction due to environmental applications like CO2 capture—a keyword with high search volume in green chemistry.

Ongoing research explores its catalytic potential in asymmetric synthesis, aligning with industry shifts toward sustainable chemistry. Queries such as "spirocycles in organocatalysis" underscore this trend. Analytical techniques like NMR and X-ray crystallography (common search terms for structural validation) are pivotal in characterizing its derivatives.

In summary, 7-methyl-6-oxa-9-azaspiro[4.5]decane (CAS No. 1018608-06-4) exemplifies the intersection of structural innovation and multidisciplinary utility. Its relevance spans drug discovery, catalysis, and advanced materials, making it a compound of enduring scientific interest. By addressing search trends like "spirocyclic drug candidates 2024" and "aza-spiro stability," this overview bridges technical depth with real-world research demands.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)